Rudnicki DD - Search Results

1

A high-throughput screening to identify small molecules that suppress huntingtin promoter activity or activate huntingtin-antisense promoter activity.

Khaled HG, Feng H, Hu X, Sun X, Zheng W, Li PP, Rudnicki DD, Ye W, Chen YC, Southall N, Marugan J, Ross CA, Ferrer M, Henderson MJ, Margolis RL. Khaled HG, et al. Among authors: rudnicki dd. Sci Rep. 2021 Mar 17;11(1):6157. doi: 10.1038/s41598-021-85279-2. Sci Rep. 2021. PMID: 33731741 Free PMC article.

2

A natural antisense transcript at the Huntington's disease repeat locus regulates HTT expression.

Chung DW, Rudnicki DD, Yu L, Margolis RL. Chung DW, et al. Among authors: rudnicki dd. Hum Mol Genet. 2011 Sep 1;20(17):3467-77. doi: 10.1093/hmg/ddr263. Epub 2011 Jun 13. Hum Mol Genet. 2011. PMID: 21672921 Free PMC article.

3

Phosphorodiamidate morpholino oligomers suppress mutant huntingtin expression and attenuate neurotoxicity.

Sun X, Marque LO, Cordner Z, Pruitt JL, Bhat M, Li PP, Kannan G, Ladenheim EE, Moran TH, Margolis RL, Rudnicki DD. Sun X, et al. Among authors: rudnicki dd. Hum Mol Genet. 2014 Dec 1;23(23):6302-17. doi: 10.1093/hmg/ddu349. Epub 2014 Jul 4. Hum Mol Genet. 2014. PMID: 25035419 Free PMC article.

4

Nuclear retention of full-length HTT RNA is mediated by splicing factors MBNL1 and U2AF65.

Sun X, Li PP, Zhu S, Cohen R, Marque LO, Ross CA, Pulst SM, Chan HY, Margolis RL, Rudnicki DD. Sun X, et al. Among authors: rudnicki dd. Sci Rep. 2015 Jul 28;5:12521. doi: 10.1038/srep12521. Sci Rep. 2015. PMID: 26218986 Free PMC article.

5

Repeat expansion and autosomal dominant neurodegenerative disorders: consensus and controversy.

Rudnicki DD, Margolis RL. Rudnicki DD, et al. Expert Rev Mol Med. 2003 Aug 22;5(21):1-24. doi: 10.1017/S1462399403006598. Expert Rev Mol Med. 2003. PMID: 14585172 Review.

6

Huntington's disease like-2: review and update.

Margolis RL, Rudnicki DD, Holmes SE. Margolis RL, et al. Among authors: rudnicki dd. Acta Neurol Taiwan. 2005 Mar;14(1):1-8. Acta Neurol Taiwan. 2005. PMID: 15835282 Review.

7

Huntington's disease--like 2 is associated with CUG repeat-containing RNA foci.

Rudnicki DD, Holmes SE, Lin MW, Thornton CA, Ross CA, Margolis RL. Rudnicki DD, et al. Ann Neurol. 2007 Mar;61(3):272-82. doi: 10.1002/ana.21081. Ann Neurol. 2007. PMID: 17387722

8

A comparison of huntington disease and huntington disease-like 2 neuropathology.

Rudnicki DD, Pletnikova O, Vonsattel JP, Ross CA, Margolis RL. Rudnicki DD, et al. J Neuropathol Exp Neurol. 2008 Apr;67(4):366-74. doi: 10.1097/NEN.0b013e31816b4aee. J Neuropathol Exp Neurol. 2008. PMID: 18379432

9

Loss of junctophilin-3 contributes to Huntington disease-like 2 pathogenesis.

Seixas AI, Holmes SE, Takeshima H, Pavlovich A, Sachs N, Pruitt JL, Silveira I, Ross CA, Margolis RL, Rudnicki DD. Seixas AI, et al. Among authors: rudnicki dd. Ann Neurol. 2012 Feb;71(2):245-57. doi: 10.1002/ana.22598. Ann Neurol. 2012. PMID: 22367996

10

Diced triplets expose neurons to RISC.

Rudnicki DD, Margolis RL, Pearson CE, Krzyzosiak WJ. Rudnicki DD, et al. PLoS Genet. 2012;8(2):e1002545. doi: 10.1371/journal.pgen.1002545. Epub 2012 Feb 23. PLoS Genet. 2012. PMID: 22383898 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters